BrainCool Seeks De Novo For Device That Prevents Oral Mucositis In Cancer Patients :: Medtech Insight
BrainCool on the benefits of uplisting to Nasdaq First North - BioStock
Market Notice 163/22 – Information regarding the rights issue from BrainCool AB
BrainCool's IQool™ system aligns with New Ame | EurekAlert!
Braincool på väg från Spotlight till First North
BrainCool AB (publ) has established direct sales operations in USA
BrainCool AB: Correction “New order on the US market for IQool™ System” published 2020-02-06
BrainCool AB (publ): Change in terms and conditions in warrants of series TO1, TO2 and TO3
Handelsstopp i Braincool upphävs
Emission: BrainCool - Analyst Group
Braincool handelsstoppad - Dagens Börs
BrainCool on the benefits of uplisting to Nasdaq First North - BioStock
FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System | Medical Product Outsourcing
BrainCool AB - Stock and Shares News | IPO HUB
BrainCool on the benefits of uplisting to Nasdaq First North - BioStock
BrainCool AB (publ) | LinkedIn
BrainCool AB (publ) - Exercise period for BrainCool's warrants, BRAIN TO 3, 2019-2022, August 24 – September 7, 2020
MFN.se > BrainCool > BrainCool AB (publ): BrainCool offentliggör bolagsbeskrivning inför notering på Nasdaq First North Growth Market
Braincool handelsstoppas
Braincool på väg från Spotlight till First North
BrainCool Seeks De Novo For Device That Prevents Oral Mucositis In Cancer Patients :: Medtech Insight
BrainCool AB (publ) | LinkedIn
Post - BrainCool | World-class medical cooling systems
The Spawn of ChatGPT Will Try to Sell You Things | WIRED
Organization - BrainCool | World-class medical cooling systems
BrainCool aktie (BRAIN) | Alla nyheter, analys, riktkurs… - Börskollen
